View More View Less
  • 1 Mashhad University of Medical Sciences, Mashhad, Iran
  • | 2 Mashhad University of Medical Sciences, Mashhad, Iran
  • | 3 Mashhad University of Medical Sciences, Mashhad, Iran
  • | 4 Mashhad University of Medical Sciences, Mashhad, Iran
  • | 5 Mashhad University of Medical Science, Mashhad, Iran
  • | 6 Mashhad University of Medical Science, Mashhad, Iran
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $784.00

ST2 is a member of IL-1 receptor family expressed on Th2 cells and regulates Th2 responces. The gene of ST2 encodes soluble ST2 (sST2) and the transmembrane ST2 (ST2L) isoforms through alternative mRNA splicing. The discovery of IL33/ ST2 signaling pathway, has drawn a great scientific attention to this system. sST2 has been shown to be an indacating factor in various infl ammatory conditions. This study aims to evaluate serum sST2 levels in HTLV-1 infected patients. This study included 49 HTLV-1 seropositive cases of which 14 were sympthomatic. Controls consisted of 30 healthy volunteers. sST2 level was measured using a quantitative ELISA assay and the results of the study groups were compared. Corroborating the previous reports, sST2 was lower in females (P = 0.003). The sST2 levels was slightly increased in HTLV-1 patients, though such increase was not statistically significant (P = 0.91), in addition sST2 level did not correlate significantly to the disease duration (P = 0.78). Despite some other chronic viral infection, HTLV-1 seems not to induce high serum sST2. However owing to relatively high normal variation of sST2 levels and rather small sample size, we stongly recommend further reseach with preferably larger sample size to evalute sST2 in HTLV-1 infected patients.

  • 1.

    Gessain, A., Cassar, O.: Epidemiological aspects and world distribution of HTLV-1 infection. Front Microbiol 3, 388 (2012).

  • 2.

    Yamano, Y., Sato, T.: Clinical pathophysiology of human T-lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesis. Front Microbiol 3, 389 (2012).

    • Search Google Scholar
    • Export Citation
  • 3.

    Yasunaga, J., Matsuoka, M.: Human T-cell leukemia virus type I induces adult T-cell leukemia: from clinical aspects to molecular mechanisms. Cancer Control 14, 133140 (2007).

    • Search Google Scholar
    • Export Citation
  • 4.

    Allan, S.M., Rothwell, N.J.: Cytokines and acute neurodegeneration. Nature Reviews Neuroscience 2, 734744 (2001).

  • 5.

    Kubota, R., Umehara, F., Izumo, S., Ijichi, S., Matsumuro, K., Yashiki, S., Fujiyoshi, T., Sonoda, S., Osame, M.: HTLV-I proviral DNA amount correlates with infiltrating CD4 lymphocytes in the spinal cord from patients with HTLV-I-associated myelopathy. J Neuroimmunol 53, 2329 (1994).

    • Search Google Scholar
    • Export Citation
  • 6.

    Nishimoto, N., Yoshizaki, K., Eiraku, N., Machigashira, K., Tagoh, H., Ogata, A., Kuritani, T., Osame, M., Kishimoto, T.: Elevated levels of interleukin-6 in serum and cerebrospinal fluid of HTLV-I-associated myelopathy/tropical spastic paraparesis. J Neurol Sci 97, 183193 (1990).

    • Search Google Scholar
    • Export Citation
  • 7.

    Tendler, C.L., Greenberg, S.J., Burton, J.D., Danielpour, D., Kim, S.J., Blattner, W.A., Manns, A., Waldmann, T.A.: Cytokine induction in HTLV-I associated myelopathy and adult T-cell leukemia: Alternate molecular mechanisms underlying retroviral pathogenesis. J Cell Biochem 46, 302311 (1991).

    • Search Google Scholar
    • Export Citation
  • 8.

    Moritz, D.R., Rodewald, H-R., Gheyselinck, J., Klemenz, R.: The IL-1 receptor-related T1 antigen is expressed on immature and mature mast cells and on fetal blood mast cell progenitors. The J Immunol 161, 48664874 (1998).

    • Search Google Scholar
    • Export Citation
  • 9.

    Oshikawa, K., Yanagisawa, K., Tominaga, S-I., Sugiyama, Y.: ST2 protein induced by inflammatory stimuli can modulate acute lung inflammation. Biochem Biophys Res Commun 299, 1824 (2002).

    • Search Google Scholar
    • Export Citation
  • 10.

    Xu, D., Chan, W.L., Leung, B.P., Huang, F., Wheeler, R., Piedrafita, D., Robinson, J.H., Liew, F.Y.: Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. J Exp Med 187, 787794 (1998).

    • Search Google Scholar
    • Export Citation
  • 11.

    Iwahana, H., Yanagisawa, K., Ito-Kosaka, A., Kuroiwa, K., Tago, K., Komatsu, N., Katashima, R., Itakura, M., Tominaga, S.: Different promoter usage and multiple transcription initiation sites of the interleukin-1 receptor-related human ST2 gene in UT-7 and TM12 cells. Eur J Biochem 264, 397406 (1999).

    • Search Google Scholar
    • Export Citation
  • 12.

    Kakkar, R., Lee, R.T.: The IL-33/ST2 pathway: therapeutic target and novel biomarker. Nat Rev Drug Discov 7, 827840 (2008).

  • 13.

    Schmitz, J., Owyang, A., Oldham, E., Song, Y., Murphy, E., McClanahan, T.K., Zurawski, G., Moshrefi, M., Qin, J., Li, X., Gorman, D.M., Bazan, J.F., Kastelein, R.A.: IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23, 479490 (2005).

    • Search Google Scholar
    • Export Citation
  • 14.

    Miller, A.M.: Role of IL-33 in inflammation and disease. J Inflamm (Lond) 8, 22 (2011).

  • 15.

    Miller, A.M., Liew, F.Y.: The IL-33/ST2 pathway — A new therapeutic target in cardiovascular disease. Pharmacol Ther 131, 179186 (2011).

    • Search Google Scholar
    • Export Citation
  • 16.

    Kumar, S., Tzimas, M.N., Griswold, D.E., Young, P.R.: Expression of ST2, an interleukin- 1 receptor homologue, is induced by proinflammatory stimuli. Biochem Biophys Res Commun 235, 474478 (1997).

    • Search Google Scholar
    • Export Citation
  • 17.

    Tajima, S., Oshikawa, K., Tominaga, S-I., Sugiyama, Y.: The increase in serum soluble ST2 protein upon acute exacerbation of idiopathic pulmonary fibrosis. Chest 124, 12061214 (2003).

    • Search Google Scholar
    • Export Citation
  • 18.

    Oshikawa, K., Yanagisawa, K., Tominaga, S., Sugiyama, Y.: Expression and function of the ST2 gene in a murine model of allergic airway inflammation. Clin Exp Allergy 32, 15201526 (2002).

    • Search Google Scholar
    • Export Citation
  • 19.

    Kuroiwa, K., Arai, T., Okazaki, H., Minota, S., Tominaga, S-I.: Identification of human ST2 protein in the sera of patients with autoimmune diseases. Biochem Biophys Res Commun 284, 11041108 (2001).

    • Search Google Scholar
    • Export Citation
  • 20.

    Oshikawa, K., Kuroiwa, K., Tago, K., Iwahana, H., Yanagisawa, K., Ohno, S., Tominaga, S.I., Sugiyama, Y.: Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation. Am J Respir Crit Care Med 164, 277281 (2001).

    • Search Google Scholar
    • Export Citation
  • 21.

    Oshikawa, K., Yanagisawa, K., Ohno, S., Tominaga, S-I., Sugiyama, Y.: Expression of ST2 in helper T lymphocytes of malignant pleural effusions. Am J Respir Crit Care Med 165, 10051009 (2002).

    • Search Google Scholar
    • Export Citation
  • 22.

    Miyagaki, T., Sugaya, M., Yokobayashi, H., Kato, T., Ohmatsu, H., Fujita, H., Saeki, H., Kikuchi, Y., Tamaki, T., Sato, S.: High levels of soluble ST2 and low levels of IL-33 in sera of patients with HIV infection. J Invest Dermatol 131, 794796 (2011).

    • Search Google Scholar
    • Export Citation
  • 23.

    Copeland, K.F., Heeney, J.L.: T helper cell activation and human retroviral pathogenesis. Microbiol Rev 60, 722742 (1996).

  • 24.

    Lu, J., Snider, J.V., Grenache, D.G.: Establishment of reference intervals for soluble ST2 from a United States population. Clin Chim Acta 411, 18251826 (2010).

    • Search Google Scholar
    • Export Citation
  • 25.

    Dieplinger, B., Januzzi, J.L., Steinmair, M., Gabriel, C., Poelz, W., Haltmayer, M., Mueller, T.: Analytical and clinical evaluation of a novel high-sensitivity assay for measurement of soluble ST2 in human plasma — the Presage ST2 assay. Clin Chim Acta 409, 33– 40 (2009).

    • Search Google Scholar
    • Export Citation
  • 26.

    Rafatpanah, H., Hedayati-Moghaddam, M.R., Fathimoghadam, F., Bidkhori, H.R., Shamsian, S.K., Ahmadi, S., Sohgandi, L., Azarpazhooh, M.R., Rezaee, S.A., Farid, R., Bazarbachi, A.: High prevalence of HTLV-I infection in Mashhad, Northeast Iran: a populationbased seroepidemiology survey. J Clin Virol 52, 172176 (2011).

    • Search Google Scholar
    • Export Citation
  • 27.

    Abbaszadegan, M.R., Gholamin, M., Tabatabaee, A., Farid, R., Houshmand, M., Abbaszadegan, M.: Prevalence of human T-lymphotropic virus type 1 among blood donors from Mashhad, Iran. J Clin Microbiol 41, 25932595 (2003).

    • Search Google Scholar
    • Export Citation
  • 28.

    Ciccone, M.M., Cortese, F., Gesualdo, M., Riccardi, R., Di Nunzio, D., Moncelli, M., Iacoviello, M., Scicchitano, P.: A novel cardiac bio-marker: ST2: a review. Molecules 18, 1531415328 (2013).

    • Search Google Scholar
    • Export Citation

 

The author instruction is available in PDF.
Please, download the file from HERE

Senior editors

Editor-in-Chief: Prof. Dóra Szabó (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Managing Editor: Dr. Béla Kocsis (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Co-editor: Dr. Andrea Horváth (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Editorial Board

  • Prof. Éva ÁDÁM (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Sebastian AMYES (Department of Medical Microbiology, University of Edinburgh, Edinburgh, UK.)
  • Dr. Katalin BURIÁN (Institute of Clinical Microbiology University of Szeged, Szeged, Hungary; Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary.)
  • Dr. Orsolya DOBAY (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Ildikó Rita DUNAY (Institute of Inflammation and Neurodegeneration, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany; Center for Behavioral Brain Sciences (CBBS), Magdeburg, Germany)
  • Prof. Levente EMŐDY(Department of Medical Microbiology and Immunology, University of Pécs, Pécs, Hungary.)
  • Prof. Anna ERDEI (Department of Immunology, Eötvös Loránd University, Budapest, Hungary, MTA-ELTE Immunology Research Group, Eötvös Loránd University, Budapest, Hungary.)
  • Prof. Éva Mária FENYŐ (Division of Medical Microbiology, University of Lund, Lund, Sweden)
  • Prof. László FODOR (Department of Microbiology and Infectious Diseases, University of Veterinary Medicine, Budapest, Hungary)
  • Prof. József KÓNYA (Department of Medical Microbiology, University of Debrecen, Debrecen, Hungary)
  • Prof. Yvette MÁNDI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Károly MÁRIALIGETI (Department of Microbiology, Eötvös Loránd University, Budapest, Hungary)
  • Prof. János MINÁROVITS (Department of Oral Biology and Experimental Dental Research, University of Szeged, Szeged, Hungary)
  • Prof. Béla NAGY (Centre for Agricultural Research, Institute for Veterinary Medical Research, Budapest, Hungary.)
  • Prof. István NÁSZ (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Kristóf NÉKÁM (Hospital of the Hospitaller Brothers in Buda, Budapest, Hungary.)
  • Dr. Eszter OSTORHÁZI (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Rozália PUSZTAI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Peter L. RÁDY (Department of Dermatology, University of Texas, Houston, Texas, USA)
  • Prof. Éva RAJNAVÖLGYI (Department of Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary)
  • Prof. Ferenc ROZGONYI (Institute of Laboratory Medicine, Semmelweis University, Budapest, Hungary)
  • Prof. Zsuzsanna SCHAFF (2nd Department of Pathology, Semmelweis University, Budapest, Hungary)
  • Prof. Joseph G. SINKOVICS (The Cancer Institute, St. Joseph’s Hospital, Tampa, Florida, USA)
  • Prof. Júlia SZEKERES (Department of Medical Biology, University of Pécs, Pécs, Hungary.)
  • Prof. Mária TAKÁCS (National Reference Laboratory for Viral Zoonoses, National Public Health Center, Budapest, Hungary.)
  • Prof. Edit URBÁN (Department of Medical Microbiology and Immunology University of Pécs, Pécs, Hungary; Institute of Translational Medicine, University of Pécs, Pécs, Hungary.)

 

Editorial Office:
Akadémiai Kiadó Zrt.
Budafoki út 187-187, A/3, H-1117 Budapest, Hungary

Editorial Correspondence:
Acta Microbiologica et Immunologica Hungarica
Institute of Medical Microbiology
Semmelweis University
P.O. Box 370
H-1445 Budapest, Hungary
Phone: + 36 1 459 1500 ext. 56101
Fax: (36 1) 210 2959
E-mail: amih@med.semmelweis-univ.hu

 Indexing and Abstracting Services:

  • Biological Abstracts
  • BIOSIS Previews
  • CAB Abstracts
  • Chemical Abstracts
  • Global Health
  • Index Medicus
  • Index Veterinarius
  • Medline
  • Referativnyi Zhurnal
  • SCOPUS
  • Science Citation Index Expanded
2020  
Total Cites 662
WoS
Journal
Impact Factor
2,048
Rank by Immunology 145/162(Q4)
Impact Factor Microbiology 118/137 (Q4)
Impact Factor 1,904
without
Journal Self Cites
5 Year 0,671
Impact Factor
Journal  0,38
Citation Indicator  
Rank by Journal  Immunology 146/174 (Q4)
Citation Indicator  Microbiology 120/142 (Q4)
Citable 42
Items
Total 40
Articles
Total 2
Reviews
Scimago 28
H-index
Scimago 0,439
Journal Rank
Scimago Immunology and Microbiology (miscellaneous) Q4
Quartile Score Medicine (miscellaneous) Q3
Scopus 438/167=2,6
Scite Score  
Scopus General Immunology and Microbiology 31/45 (Q3)
Scite Score Rank  
Scopus 0,760
SNIP
Days from  225
sumbission
to acceptance
Days from  118
acceptance
to publication
Acceptance 19%
Rate

2019  
Total Cites
WoS
485
Impact Factor 1,086
Impact Factor
without
Journal Self Cites
0,864
5 Year
Impact Factor
1,233
Immediacy
Index
0,286
Citable
Items
42
Total
Articles
40
Total
Reviews
2
Cited
Half-Life
5,8
Citing
Half-Life
7,7
Eigenfactor
Score
0,00059
Article Influence
Score
0,246
% Articles
in
Citable Items
95,24
Normalized
Eigenfactor
0,07317
Average
IF
Percentile
7,690
Scimago
H-index
27
Scimago
Journal Rank
0,352
Scopus
Scite Score
320/161=2
Scopus
Scite Score Rank
General Immunology and Microbiology 35/45 (Q4)
Scopus
SNIP
0,492
Acceptance
Rate
16%

 

Acta Microbiologica et Immunologica Hungarica
Publication Model Online only Hybrid
Submission Fee none
Article Processing Charge 1100 EUR/article
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription fee 2021 Online subsscription: 652 EUR / 812 USD
Subscription fee 2022 Online subsscription: 662 EUR / 832 USD
Print + online subscription: 740 EUR / 930 USD
Subscription Information Online subscribers are entitled access to all back issues published by Akadémiai Kiadó for each title for the duration of the subscription, as well as Online First content for the subscribed content.
Purchase per Title Individual articles are sold on the displayed price.

Acta Microbiologica et Immunologica Hungarica
Language English
Size A4
Year of
Foundation
1954
Publication
Programme
2021 Volume 68
Volumes
per Year
1
Issues
per Year
4
Founder Magyar Tudományos Akadémia
Founder's
Address
H-1051 Budapest, Hungary, Széchenyi István tér 9.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 1217-8950 (Print)
ISSN 1588-2640 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Apr 2021 8 0 0
May 2021 4 0 0
Jun 2021 2 0 0
Jul 2021 1 0 0
Aug 2021 2 0 0
Sep 2021 1 0 0
Oct 2021 0 0 0